DGAP-News

MOLOGEN AG: Medium-term funding from existing capital authorizations possible

DGAP-News: MOLOGEN AG / Key word(s): Financing
MOLOGEN AG: Medium-term funding from existing capital authorizations
possible

05.07.2016 / 16:15
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR
INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER
JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

PRESS RELEASE N 10 / 2016 of 07/05/2016

MOLOGEN AG: Medium-term funding from existing capital authorizations
possible

Berlin, 5 July 2016 - Since announcing its "Next Level" strategy program on
9 June 2016, MOLOGEN AG (ISIN DE0006637200/WKN 663720) has continued to
analyze its capital requirement to fund its business operations as well as
carrying out an in-depth analysis of the market. The findings from this
process are that the Company's likely funding requirement in conjunction
with the implementation of the "Next Level" program can be covered from
existing authorized capital together with the existing authorization to use
conditional capital. In light of this, the Executive Management Board has
decided, with the consent of the Supervisory Board, not to propose the
resolution regarding a capital measure to the Company's Annual General
Meeting on 11 August 2016. Instead, in view of the greater flexibility
involved, the Company is currently planning to carry out a cash capital
increase from authorized capital flanked, if necessary, by a measure using
the conditional capital, depending on market conditions and subject to
approval of an appropriate securities prospectus.


Important note:

This announcement does not contain or constitute an offer of, or the
solicitation of an offer to buy or subscribe for, securities to any person
in the United States, Australia, Canada, Japan or in any jurisdiction to
whom or in which such offer or solicitation is unlawful.

This release is not a prospectus. Investors should not purchase or
subscribe for any shares referred to in this press release except on the
basis of information in a prospectus to be issued by the Company in
connection with the offering of such shares.

This release is not an offer of securities for sale in the United States of
America. The securities referred to in this press release have not been,
and will not be, registered under the US Securities Act of 1933, as amended
(the "Securities Act"), and may not be offered or sold in the United States